Stock Spotlight: Treasury Wine Estates Limited (ASX:TWE)

This week's Stock Spotlight is ASX-listed Treasury Wine Estates Limited.


About Treasury Wine Estates Limited.


Treasury Wine Estates Limited operates as a wine company primarily in Australia, the United States, the United Kingdom, and internationally. The company engages in the viticulture and winemaking; and marketing, sale, and distribution of wine. Its wine portfolio includes luxury, premium and commercial wine brands, such as Penfolds, DAOU Vineyards, Wolf Blass, 19 Crimes, St Hubert's The Stag, Lindeman's, Squealing pig, Blossom Hill, Frank Family Vineyards, Pepperjack, Wynns, Matua, Seppelt, Beringer, Etude, Sterling Vineyards, Beaulieu Vineyard, Stags' Leap, Beringer Bros, and Castello di Gabbiano. The company also provides contract bottling services to third parties; and sells grape and bulk wine. It owns and leases vineyards in Australia and New Zealand, California, France, and Italy. The company markets and sells its products to distributors, wholesalers, retails chains, independent retailers, and on-premise outlets, as well as directly to consumers. The company was founded in 1843 and is headquartered in Melbourne, Australia.


Source: Yahoo Finance



Key Stats

Source: Yahoo Finance. Data as of 08/09/25.


Price Performance

Growth Potential

  • Trading below our revised valuation. TWE’s share price has been very weak (absolute & relative) over the past 12 months.
  • China’s removal of tariffs on Australian wine should be a positive over the medium-term.
  • Significant opportunity to grow its Asian business which will provide a more balanced exposure to the region rather than one specific country.
  • Group margin surprise on the upside due to premiumization & good cost control.
  • The turnaround in Americas business could lead to significantly higher margins.
  • Favorable currency movements (leveraged to a falling AUD/USD).
  • Capital management – TWE currently has a $200m on-market buyback.

Key Risks


  • Recovery in China disappoints relative to expectations.
  • New CEO revises earnings guidance for the key Penfolds business.
  • Slowdown in wine consumption in key markets (including structural changing to consumption).
  • Adverse movement in global wine supply and demand.
  • Increase competition in key markets or moderating pricing power.
  • Unfavorable currency movements (negative translation effect).

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Speak to an Advisor

September 15, 2026
The AI trade is being forced to rethink the pace of progress. Here is what investors should watch across Nvidia, chips, AI spending, software and adoption.
September 9, 2026
Copper is at a record high, yet the global market still has a surplus. So where is all the copper, and why is it becoming harder to find?
By Lavender Wong September 1, 2026
Sharewise CEO Alex Perry sat down with ausbiz to unpack how the platform approached FY26, a year in which it reported an ASX return of almost 11% and a US return above 32%. The conversation ranged from the AI infrastructure theme to specific names on Perry's radar in resources and quantum computing. Here's a rundown of the key points.
August 31, 2026
Warsh gave markets a framework, not a forecast. What his first Jackson Hole keynote means for inflation, rates, forward guidance and the outlook for equities.
August 26, 2026
Get the latest on Impact Minerals (ASX: IPT), including stock performance, technical analysis, forecasts & key insights. See if IPO supports your goals.
August 26, 2026
Get the latest on Valiant Gold (ASX: VAL) with our share price, technical analysis, forecasts & key insights. See if this ASX gold stock fits your investment goals.
August 26, 2026
Learn about Percheron Therapeutics (ASX: PER). Offering share price, technical analysis, forecasts & insights. See if this ASX biotech stock fits your goals.
August 19, 2026
Brent crude hits US$91 as US-Iran talks stall and Strait of Hormuz disruption persists. What's driving the move and what comes next for oil
August 13, 2026
The RBA holds rates at 4.35% as inflation remains elevated. Here’s what the August decision means for the Australian economy, markets and key sectors.
August 6, 2026
As AI becomes cheaper to deploy, could the next investment winners shift beyond chipmakers? Explore how the AI cost race is redefining future tech leaders.